A partnership between CEPI, Barinthus Biotherapeutics and the University of Oxford aims to fast-track the development of a potential vaccine for the prevention of Middle East Respiratory Syndrome (MERS).
Scientific advisors to the International Pandemic Preparedness Secretariat (IPPS) visited the University of Oxford\u2019s vaccine laboratories as part of a two-day meeting of the global coalition.
CEPI will provide up to $25 million to the University of Oxford to complete early development of prototype vaccines against the Jun\u00edn virus, with a new project led by Professor Teresa Lambe.
The RECOVERY trial, the leading global clinical trial of treatments for COVID-19, has expanded to find effective treatments for patients hospitalised with flu.
Clinical researchers and representatives from the World Health Organization defined a bold new path for global research collaboration in acute care at a conference co-hosted by ISARIC, a global federation of investigator-led clinical research networks.
The University of Oxford has launched a new global vaccine collaboration, backed by \u00a38 million funding from UK Research and Innovation (UKRI), and led by two PSI Principal Investigators.
The UK trial is the next step in the development of a vaccine to protect people against MERS \u2013 a deadly viral illness with no current vaccines and the potential to cause a pandemic.
A University of Oxford study has administered a new vaccine against tick-borne virus Crimean-Congo haemorrhagic fever (CCHF) to volunteers for the first time.
The Coalition for Epidemic Preparedness Innovations (CEPI) and the University of Oxford have entered into a strategic partnership to accelerate the development of safe, effective and globally accessible vaccines to counter the threat of future pandemics.
Oxford Vaccine Group and Pandemic Sciences Institute\u2019s Professor Pollard speaks to the people who shaped the COVID-19 pandemic in his new podcast, The Oxford Colloquy.
A new Future Vaccines Manufacturing Hub \u2013 co-led by University of Oxford and University College London \u2013 aims to make the UK the global centre for discovering and manufacturing next-generation vaccines.
The inaugural MRC Impact Prize recognises teams who have made outstanding impacts in health and medical research. The winners will be announced at a ceremony in the spring.
A vaccine developed by the Oxford Vaccine Group\u2019s Prof Teresa Lambe and supported in clinical trials and manufacture scale-up by researchers from the Jenner Institute (Nuffield Department of Medicine) has been recommended for inclusion in a ring vaccination trial to combat a Sudan ebolavirus outbreak in Uganda.
The Pandemic Sciences Institute is hosting the UK GOARN partners this week to discuss hot topics such as operational research and rapid response capacity during outbreaks.
The UK\u2019s efforts to tackle the monkeypox outbreak will receive a huge boost with the creation of a new research consortium \u2013 in which the University of Oxford is a key partner \u2013 working together to develop better diagnostic tests, identify potential therapies and study vaccine effectiveness.
The team behind the world-leading RECOVERY trial of COVID-19 treatments are leading a new study investigating a potential treatment for people who have been diagnosed with monkeypox. The National Institute for Health and Care Research (NIHR) has commissioned and funded the study. The first patients have now been recruited.
Dame Sarah Gilbert, 60, is a professor of vaccinology at Oxford\u2019s Jenner Institute and author, with Catherine Green, head of Oxford University\u2019s clinical biomanufacturing facility, of Vaxxers \u2013 a gripping narrative about developing the AstraZeneca vaccine that is wonderfully accessible and illuminating without dumbing down the science. She lives in Oxford with her husband and grownup triplets.
One trial. Over 47,000 participants. Nearly 200 hospital sites, across six countries. Ten results. Four effective COVID-19 treatments. And behind them all, an army of countless researchers, doctors, nurses, statisticians and supporting staff.
![\"Healthworker](\"https://www.psi.ox.ac.uk/news-and-opinion/new-partnership-aims-to-advance-vaccine-against-mers-coronavirus/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n